Evaluation of 7-benzyloxy-4-trifluoromethylcoumarin, some other 7-hydroxy-4-trifluoromethylcoumarin derivatives and 7-benzyloxyquinoline as fluorescent substrates for rat hepatic cytochrome P450 enzymes

被引:25
作者
Renwick, AB
Lavignette, G
Worboys, PD
Williams, B
Surry, D
Lewis, DFV
Price, RJ
Lake, BG
Evans, DC
机构
[1] TNO BIBRA Int Ltd, Carshalton SM5 4DS, Surrey, England
[2] Univ Bourgogne, ENS BANA, F-21100 Dijon, France
[3] Merck Sharp & Dohme Ltd, Neurosci Res Ctr, Harlow CM20 2QR, Essex, England
[4] Univ Surrey, Sch Biomed & Life Sci, Guildford GU2 5XH, Surrey, England
[5] Merck & Co Inc, Drug Metab, Rahway, NJ 07065 USA
关键词
D O I
10.1080/00498250110074063
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1. The aim of this study was to evaluate a number of derivatives of 7-hydroxy-4-trifluoromethylcoumarin (HFC) and 7-benzyloxyquinoline (7BQ) as novel fluorescent substrates for monitoring rat hepatic cytochrome P450 (CYP) enzyme specificity in a 96-well plate format. The HFC derivatives examined comprised 7-benzyloxy-4-trifluoromethylcoumarin (BFC), 2,5-bis(trifluoromethyl)-7-benzyloxy-4-trifluoromethylcoumarin (BFBFC), 3,5-bis(trifluoromethyl)-7-benzyloxy-4-trifluoromethylcoumarin (BTBFC), 2-(trifluoromethyl)-7-benzyloxy-4-trifluoromethylcoumarin (2TFBFC), 3-(trifluoromethyl) -7-benzyloxy-4-trifluoromethylcournarin (3TFBFC) and 3-(trifluoromethoxy)-7-benzyloxy-4-trifluoromethylcoumarin (3TFMeOBFC). 2. The CYP specificity of the fluorescent probe substrates was examined using characterized liver microsomes from male Sprague-Dawley rats treated with beta -naphthoflavone (BNF), sodium phenobarbitone (NaPB), isoniazid, pregnenolone-16 alpha -carbonitrile (PCN), dexamethasone (DEX) and methylclofenapate to induce CYP1A, CYP2B, CYP2E, CYP3A, CYP3A and CYP4A forms, respectively. Studies were also performed with microsomes from baculovirus-infected insect cells containing rat cDNA-expressed CYP1A1, CYP1A2, CYP2B1, CYP3A1 and CYP3A2. 3. BFC metabolism was most markedly induced by BNF and NaPB, whereas BFBFC metabolism was most markedly induced by PCN and DEX and BTBFC was not metabolized by rat liver microsomes. BFC was a high-affinity substrate for cDNA-expressed CYP1A1 and CYP2B1, whereas BFBFC exhibited a high affinity for CYP3A1 and CYP3A2. 4. The metabolism of 2TFBFC and 3TFBFC was induced by NaPB, PCN and DEX. 3TFBFC was a relatively specific substrate for cDNA-expressed CYP2B1, whereas 2TFBFC could be metabolized by CYP2B1, CYP3A1 and CYP3A2. 5. 3TFMeOBFC metabolism was markedly induced by BNF treatment and 3TFMeOBFC was extensively metabolized by cDNA-expressed CYP1A1. 6. The metabolism of 7BQ to 7-hydroxyquinoline was induced by treatment with PCN and DEX. 7BQ was a substrate for cDNA-expressed CYP3A2 and to a lesser extent for CYP3A1. 7. In summary, some of the HFC derivatives studied and 7BQ are useful fluorescent probe substrates for rat CYP enzymes. BFC appears to be a probe for CYP1A and CYP2B, 2TFBFC for CYP2B and CYP3A and 3TFBFC for CYP2B. While 3TFMeOBFC appears to be a relatively specific probe for CYP1A1, both BFBFC and 7BQ are good probes for the induction of CYP3A.
引用
收藏
页码:861 / 878
页数:18
相关论文
共 41 条
[11]  
Gomez-Lechon M.J., 1997, IN VITRO METHODS IN PHARMACEUTICAL RESEARCH, P129
[12]   EVIDENCE FOR AND POSSIBLE MECHANISMS OF NONGENOTOXIC CARCINOGENESIS IN RODENT LIVER [J].
GRASSO, P ;
HINTON, RH .
MUTATION RESEARCH, 1991, 248 (02) :271-290
[13]   PEROXISOME PROLIFERATION IN PRIMARY CULTURES OF RAT HEPATOCYTES [J].
GRAY, TJB ;
LAKE, BG ;
BEAMAND, JA ;
FOSTER, JR ;
GANGOLLI, SD .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1983, 67 (01) :15-25
[14]   EFFECT OF TREATMENT WITH PYRAZINE AND SOME DERIVATIVES ON CYTOCHROME-P450 AND SOME ENZYME-ACTIVITIES IN RAT-LIVER [J].
JAPENGA, AC ;
DAVIES, S ;
PRICE, RJ ;
LAKE, BG .
XENOBIOTICA, 1993, 23 (02) :169-179
[15]  
Lake B. G., 1987, BIOCH TOXICOLOGY PRA, P183
[16]   Comparison of the effects of some CYP3A and other enzyme inducers on replicative DNA synthesis and cytochrome P450 isoforms in rat liver [J].
Lake, BG ;
Renwick, AB ;
Cunninghame, ME ;
Price, RJ ;
Surry, D ;
Evans, DC .
TOXICOLOGY, 1998, 131 (01) :9-20
[17]   MECHANISMS OF HEPATOCARCINOGENICITY OF PEROXISOME-PROLIFERATING DRUGS AND CHEMICALS [J].
LAKE, BG .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1995, 35 :483-507
[18]  
LAKE BG, 1997, COMPREHENSIVE TOXICO, V9, P233
[19]  
LAKE BG, 1996, CYTOCHROMES P450 MET, P271
[20]   Inhibition and induction of cytochrome P450 and the clinical implications [J].
Lin, JH ;
Lu, AYH .
CLINICAL PHARMACOKINETICS, 1998, 35 (05) :361-390